@article{JTD10604,
author = {Prabhat Singh Malik and Navneet Singh},
title = {ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {11},
year = {2016},
keywords = {},
abstract = {Targeting driver mutations in oncogene addicted advanced non-small cell lung cancer (NSCLC) has revealed the Achilles heel and revolutionized its management in the last one decade (1). At present, approximately 2/3rd of lung adenocarcinomas can be classified based on the driver genomic alteration (2). Anaplastic lymphoma kinase (ALK) gene rearrangement, particularly EML4-ALK fusion is seen in 3−7% patients of NSCLC, more so in younger patients and non-smokers (3-5).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/10604}
}